The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
The global hemostats market size is projected to reach USD 2.76 billion by 2020, at a CAGR of 6.2% during from 2015 to 2020. Increasing number of surgery procedures and increasing number of insurance providers to bear the high cost of this medical devices like hemostats products, are the major factors influencing the growth of this market.The administration and monitoring of hemostats during surgical procedures is a complex task for clinicians, as it depends upon the blood flow from the particular area of surgery. The usage of hemostats have no adverse effects and is an important procedure to prevent blood loss in patients, especially among the aging population. The market for hemostats is rapidly increasing with technological advancements and increasing number of surgeries. Also, hospitals and healthcare facilities are gradually increasing, supported by government which in turn is driving the growth of the hemostats market.
Hemostats is one of the sub-markets of wound closure devices. Over the years, these products have been used during surgeries to stop bleeding within a short span of time. These products are biodegradable, absorbable, and cost-effective. They have a tenure of maximum 2 years with no adverse effects.
Based on product type, this market is segmented into thrombin based hemostats, combination hemostats, oxidized regenerated cellulose based hemostats, gelatin based hemostats, and collagen based hemostats, thrombin based hemostats, combination hemostats, oxidized regenerated cellulose based hemostats, gelatin based hemostats, and collagen based hemostats.
Based on geography, the global hemostats market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The growth in the Americas hemostats market is attributed to the increase in number of surgical procedures. However, the hemostats market in Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period. Increasing healthcare infrastructure along with rise in number of surgeries are propelling the growth of this market.
The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis. Some of the companies profiled in this report are Johnson & Johnson Services, Inc. (U.S.). C. R. Bard, Inc. (U.S.), Baxter (U.S.), B Braun Melsungen AG (Germany), Pfizer Inc. (U.S.), Vascular Solutions, Inc. (U.S.), Gelita Medical GmbH (Germany), Equimedical (Netherlands), Integra Lifesciences Holdings Corporation (U.S.), Z-Medica, LLC (U.S.), and Marine Polymer Technologies, Inc. (U.S.).
Reasons To Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis, market share analysis of top players, supply chain analysis, and company profiles. All of these together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities for the global Hemostats market.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies to strengthen their market share.
The report provides insights on the following pointers:
- Product Analysis and Development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the global hemostats market are provided.
- Market Development: Comprehensive information about lucrative emerging markets is provided. The report also analyzes the markets for hemostats across various regions, exploit new distribution channels, new clientele base, and different pricing policies.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the global hemostats market is provided. Detailed description regarding the related and unrelated diversification pertaining to this market is also provided.
- Competitive Assessment: An in-depth assessment of market shares and company share analysis of the key players forecasted till 2020 is provided.